Increased tumour mass in the KO‐TRAMP and A537T‐TRAMP compared with the WT‐TRAMP prostates is further apparent in Fig 3C, showing that the Elac2 mutations exacerbate prostate tumorigenesis. Here, ELAC2 is linked to neoplasm.